Global Catalepsy Treatment Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2023 –2030 |
 Market Size (Base Year) |
USD 82.00 Billion |
 Market Size (Forecast Year) |
USD 132.68 Billion |
 CAGR |
% |
| Major Markets Players |
全球僵直症治疗市场，按治疗（药物、心理治疗、其他）、给药途径（口服、肠外和其他）、最终用户（医院、专科诊所、其他）、分销渠道（医院药房、零售药房、网上药房和其他）划分 - 行业趋势和预测到 2030 年。
僵直症治疗市场分析和规模
强直性昏厥可能由一系列疾病引起。强直性昏厥通常伴随紧张症，这是一种精神运动障碍。强直性昏厥是紧张症的十二种症状之一。它可能由精神分裂症、癫痫、药物毒性或帕金森病引起。抗精神病药物和肌肉松弛剂是两种用于治疗强直性昏厥的治疗方法。
Data Bridge Market Research 分析了 2023-2030 年预测期内僵直症治疗市场的增长率。在上述预测期内，僵直症市场的预期复合年增长率趋于 6.20% 左右。2022 年市场价值为 820 亿美元，到 2030 年将增长至 1326.8 亿美元。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、渠道分析、定价分析和监管框架。
僵直症治疗市场范围和细分
|
报告指标 |
细节 |
|
预测期 |
2023 至 2030 年 |
|
基准年 |
2022 |
|
历史岁月 |
2021（可定制为 2015 - 2020） |
|
定量单位 |
收入（单位：十亿美元）、销量（单位：台）、定价（美元） |
|
涵盖的领域 |
治疗（药物、心理治疗等）、给药途径（口服、肠胃外等）、最终用户（医院、专科诊所等）、分销渠道（医院药房、零售药房、网上药房等） |
|
覆盖国家 |
北美洲的美国、加拿大和墨西哥、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲其他地区 |
|
涵盖的市场参与者 |
GSK Plc. (U.K.), Bayer AG (Germany), Novartis AG (Switzerland), Sanofi (France), Takeda Pharmaceutical Company Limited (Japan), F. Hoffmann-La Roche Ltd (Switzerland), Abbott (U.S.), Pfizer Inc. (U.S.), Mylan N.V. (U.S.), Upsher-Smith Laboratories, LLC (U.S.), Piramal Enterprises Ltd. (India), Vintage Labs (India)., Hikma Pharmaceuticals PLC (U.K.), Endo International plc (Ireland), CASI Pharmaceuticals Inc. (U.S.), ECI Pharmaceuticals (Florida), Bristol-Myers Squibb Company (U.S.), Covis Pharma GmbH (Canada), Sumitomo Pharma Co., Ltd (Japan), Biocon (India), Eisai Co., Ltd (Japan), Cipla Inc (India), Glenmark Pharmaceuticals Limited (India), Mankind Pharma (India), Novo Nordisk A/S (Denmark), Otsuka America Pharmaceutical, Inc (Japan), and WOCKHARDT (India) |
|
Market Opportunities |
|
Market Definition
Catalepsy is the state of marked loss of voluntary mobility wherein the limbs remain in whatever posture they are placed. The typical symptoms include muscle rigidity, voluntary motion loss, fixed posture, and diminished pain sensitivity. It can be a sign of numerous of diseases, epilepsy, substance abuse, Parkinson's disease, catatonia, schizophrenia, and as a side effect of certain types of schizophrenia treatment.
Catalepsy Treatment Market Dynamics
Drivers
- Growing Prevalence Of Chronic Diseases
Chronic conditions are on rise worldwide. The unequal intra-urban inequities in access to the wide healthcare services leads to the problems faced by urban people. Elderly people, women and people living below the poverty line had higher odds of chronic conditions. Approximately 80 % of these deaths occur in low- and middle-income countries. The incidence of chronic conditions is increasing worldwide. In 2014, around 60 % of all the deaths in India were because of non-communicable diseases and the high burden is projected to increase over the time. Some common chronic diseases are somewhat increasing the incidence of catalepsy. This boost the treatment market.
Opportunities
- Growing Number Of R&D Activities
Numerous projected introduction of many novel developing drugs and widen availability of advantageous reimbursement policies are expected to have much beneficial effects. Other factors that causes the market expansion includes increased government funding for R&D and improved regulatory environment for the healthcare sector. Numerous technological advancements and greater investments in R&D activities have caused the discovery of several novel treatment options. Numerous new trends, such as companies focusing on increase in research and development spending on different neurological disorders are helping to develop novel medicines for treatment of this syndrome. Additionally, numerous clinical trials are conducted on many compounds; and some are in the research process. Several research showed that medications, such as tricyclic antidepressants, zolpidem, benzodiazepines, carbamazepine, and muscle relaxants may prove to be very effective in decreasing the symptoms of catalepsy. In addition to this, pharmacotherapy of Parkinson-induced catalepsy may include dopamine agonists and decarboxylase inhibitors among others. This enhances the market growth.
Restraints/Challenges
- High Cost of Treatment
The increased expenditure that is required for the treatment processes hampers the market growth. Several market players make vast investments in manufacturing new and advanced treatment procedures to improve the recovery process, and thus in return, the cost is increased. This hampers the market growth.
This catalepsy treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the catalepsy treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Catalepsy Treatment Market Scope
The catalepsy treatment market is segmented on the basis of treatment, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Treatment
- Drugs
- Psychotherapy
- Others
Route of Administration
- Oral
- Parenteral
- Others
End-Users
- Hospitals
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacies
- Others
Catalepsy Treatment Regional Analysis/Insights
The catalepsy treatment market is analyzed and market size insights and trends are provided by treatment, route of administration, distribution channel and end-user as referenced above.
The major countries covered in the Catalepsy treatment market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America is dominating the market in the forecast period due to the increased incidence of neurological disorders, advanced technology for the diagnosis and treatment in this region.
Asia-Pacific is considered to grow over the coming years because of the continuously increasing population leading to sincreasing prevalence of neurological disorders.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Catalepsy Treatment Share Analysis
The catalepsy treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to catalepsy treatment market
Key players operating in the catalepsy treatment market include:
- GSK Plc. (U.K.)
- Bayer AG (Germany)
- Novartis AG (Switzerland)
- ALEVA NEUROTHERAPEUTICS (Switzerland)
- Sanofi (France)
- Takeda Pharmaceutical Company Limited (Japan)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Abbott (U.S.)
- Pfizer Inc. (U.S.)
- Johnson & Johnson Services, Inc. (India)
- Dr. Reddy’s Laboratories Ltd. (India)
- Mylan N.V. (U.S.)
- Upsher-Smith Laboratories, LLC (U.S.)
- Piramal Enterprises Ltd. (India)
- Vintage Labs (India)
- Hikma Pharmaceuticals PLC (U.K.)
- Endo International plc (Ireland)
- CASI Pharmaceuticals Inc. (U.S.)
- ECI Pharmaceuticals (Florida)
- Bristol-Myers Squibb Company (U.S.)
- Covis Pharma GmbH (Canada)
- Sumitomo Pharma Co., Ltd (Japan)
- Biocon (India), Eisai Co., Ltd (Japan)
- Cipla Inc (India)
- Glenmark Pharmaceuticals Limited (India
- Mankind Pharma（印度）
- 诺和诺德公司（丹麦）
- 大冢美国制药公司 (日本)
- WOCKHARDT（印度）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
